People · Operator
Named in public records as an officer, director or promoter · active 2021–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Graphite Bio, Inc. | — | Biotechnology | Series D+ | $150.7M | $4.9B | 2021 |
| Septerna, Inc. | — | Biotechnology | Series C | $73.5M | $963.7M | 2023 |
| CARGO Therapeutics, Inc. | — | Biotechnology | Series C | $68.8M | $1.0B | 2023 |
| Rani Therapeutics Holdings, Inc. | — | Biotechnology | Series C | $60.3M | $326.1M | 2025 |
Abraham Bassan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Abraham Bassan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jerel Davis | 1 | 13 |
| Heath Lukatch | 1 | 10 |
| Carlo Rizzuto | 1 | 7 |
| Mir Imran | 1 | 6 |
| Jake Simson | 1 | 6 |
| Dennis Ausiello | 1 | 4 |
| Alan Ezekowitz | 1 | 4 |
| Jeffrey Tong | 1 | 2 |
| Perry Karsen | 1 | 2 |
| Mir Hashim | 1 | 2 |
| Jean-Luc Butel | 1 | 2 |
| Talat Imran | 1 | 2 |
| Svai Sanford | 1 | 2 |
| Matthew Porteus | 1 | 2 |
| Josh Lehrer | 1 | 2 |
| Cassandra Gianna Luca | 1 | 2 |
| Katherine Stultz | 1 | 2 |
| Krishnan Viswanadhan | 1 | 2 |
| John Orwin | 1 | 2 |
| Elizabeth Bhatt | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.